New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.1, 2011-02, pp. : 13-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia

Current Drug Therapy, Vol. 7, Iss. 4, 2012-12 ,pp. : 281-289

Bentham Science Publishers

Access to resources Recommend Favorite

Anti‐CD20 inhibits T cell‐mediated pathology and microgliosis in the rat brain

Annals Of Clinical And Translational Neurology, Vol. 1, Iss. 9, 2014-09 ,pp. : 659-669

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia

By Ali Sharmila Binte Shamshad

International Journal of Evidence-based Healthcare, Vol. 11, Iss. 2, 2013-06 ,pp. : 145-146

Blackwell Publishing

Access to resources Recommend Favorite

Monoclonal Antibodies in Cancer Treatment: A Review of Recent Progress

By Alpaugh K. von Mehren M.

BioDrugs, Vol. 12, Iss. 3, 1999-09 ,pp. : 209-236

Adis International

Access to resources Recommend Favorite

Pilot clinical trial of an anti-TNF monoclonal antibody for the treatment of septic shock

By BOILLOT A CAPELLIER G RACADOT E WIJDENES J HERVE P BARALE F

Clinical Intensive Care, Vol. 6, Iss. 2, 1995-04 ,pp. : 52-52

Ashgate Publishing Ltd

Access to resources Recommend Favorite